Opinion

Video

Real-World Data for Risdiplam in Adult Patients with Spinal Muscular Atrophy

Panelists examine the available real-world data (RWD) on the use of risdiplam in adult patients with spinal muscular atrophy (SMA) from various studies conducted worldwide, discussing its potential efficacy and safety as a treatment option for adult SMA patients.

Related Videos
Marcello Moccia, MD, PhD
Mikael Cohen, MD
Wallace Brownlee, MBChB, PhD, FRACP
Tom Fuchs, MD, PhD
Valentin Krüger, MD
Shamik Bhattacharyya, MD
Phillip Kuo, MD
Igor Koralnik, MD
© 2025 MJH Life Sciences

All rights reserved.